Clinical Pharmacology Update
HMG-CoA reductase inhibitors
A new approach to the management of hypercholesterolemia
Michael D. Cressman, DO, Byron J. Hoogwerf, MD, Douglas S. Moodie, MD, Jeffrey W. Olin, DO and Cheryl E. Weinstein, MD
Cleveland Clinic Journal of Medicine January 1988, 55 (1) 93-100;
Donald G. Vidt
Alan W. Bakst
Michael D. Cressman
Department of Heart and Hypertension Research, The Cleveland Clinic Foundation
Department of Hypertension and Nephrology, The Cleveland Clinic Foundation
Byron J. Hoogwerf
Department of Endocrinology, The Cleveland Clinic Foundation
Douglas S. Moodie
Department of Pediatric and Adolescent Medicine, The Cleveland Clinic Foundation
Department of Cardiology, The Cleveland Clinic Foundation
Jeffrey W. Olin
Department of Peripheral Vascular Disease, The Cleveland Clinic Foundation
Cheryl E. Weinstein
Department of Internal Medicine, The Cleveland Clinic Foundation

Article Information
vol. 55 no. 1 93-100
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 1, 1987
- Accepted September 1, 1987
- Published online January 1, 1988.
Copyright & Usage
Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved.
Other Contributors
- Donald G. Vidt [MD]
- Alan W. Bakst [PharmD, RPh]
Cited By...
In this issue
Cleveland Clinic Journal of Medicine
Vol. 55, Issue 1
1 Jan 1988
HMG-CoA reductase inhibitors
Michael D. Cressman, Byron J. Hoogwerf, Douglas S. Moodie, Jeffrey W. Olin, Cheryl E. Weinstein
Cleveland Clinic Journal of Medicine Jan 1988, 55 (1) 93-100;
Jump to section
Related Articles
- No related articles found.